Disorders of Water and Salt Metabolism Associated with Pituitary Disease

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 1, 2008, Pages 213-234

  Loh, Jennifer A ^a   Verbalis, Joseph G ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUID BALANCE; HUMAN; HYPEROSMOLARITY; HYPOPHYSIS DISEASE; METABOLIC DISORDER; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SODIUM BALANCE;

ARGININE VASOPRESSIN; DIABETES INSIPIDUS, NEUROGENIC; HUMANS; HYPERNATREMIA; HYPONATREMIA; OSMOLAR CONCENTRATION; WATER; WATER-ELECTROLYTE IMBALANCE;

EID: 38349117764     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.10.008     Document Type: Review

References (62)

1. Rai A., Whaley-Connell A., McFarlane S., et al. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism. Am J Nephrol 26 6 (2006) 579-589
2. Palevsky P.M., Bhagrath R., and Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 124 2 (1996) 197-203
3. Knepper M.A. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 272 1 Pt 2 (1997) F3-F12
4. Verbalis J.G. Ten essential points about body water homeostasis. Horm Res 67 Suppl 1 (2007) 165-172
5. Robertson G.L. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 30 3 (2001) 671-694
6. Sklar A.H., and Schrier R.W. Central nervous system mediators of vasopressin release. Physiol Rev 63 4 (1983) 1243-1280
7. Sladek C.D. Regulation of vasopressin release by neurotransmitters, neuropeptides and osmotic stimuli. Prog Brain Res 60 (1983) 71-90
8. Verbalis J.G. Management of disorders of water metabolism in patients with pituitary tumors. Pituitary 5 2 (2002) 119-132
9. Moder K.G., and Hurley D.L. Fatal hypernatremia from exogenous salt intake: report of a case and review of the literature. Mayo Clin Proc 65 12 (1990) 1587-1594
10. Smith D., Finucane F., Phillips J., et al. Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma. Clin Endocrinol (Oxf) 61 2 (2004) 273-279
11. Adler S.M., and Verbalis J.G. Disorders of body water homeostasis in critical illness. Endocrinol Metab Clin North Am 35 4 (2006) 873-894
12. Robinson A.G., and Verbalis J.G. The posterior pituitary. In: Larsen P.R., Kronenberg H.M., Melmed S., et al. (Eds). Williams textbook of endocrinology. 10th edition (2003), W.B. Saunders, Philadelphia 281-329
13. Nemergut E.C., Zuo Z., Jane Jr. J.A., et al. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 103 3 (2005) 448-454
14. Verbalis J.G., Robinson A.G., and Moses A.M. Postoperative and post-traumatic diabetes insipidus. In: Czernichow P., and Robinson A.G. (Eds). Diabetes insipidus in man (1984), Karger, Basel (Germany) 247-265
15. Verbalis J.G. Diabetes insipidus. Rev Endocr Metab Disord 4 2 (2003) 177-185
16. Robinson A.G. Disorders of antidiuretic hormone secretion. Clin Endocrinol Metab 14 (1985) 55-88
17. Singer I., Oster J.R., and Fishman L.M. The management of diabetes insipidus in adults. Arch Intern Med 157 12 (1997) 1293-1301
18. Tien R., Kucharczyk J., and Kucharczyk W. MR imaging of the brain in patients with diabetes insipidus. AJNR Am J Neuroradiol 12 (1991) 533-542
19. Maghnie M., Genovese E., Bernasconi S., et al. Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus. AJNR Am J Neuroradiol 18 9 (1997) 1749-1752
20. Brooks B.S., el Gammal T., Allison J.D., et al. Frequency and variation of the posterior pituitary bright signal on MR images. AJNR Am J Neuroradiol 10 5 (1989) 943-948
21. Hollinshead W.H. The interphase of diabetes insipidus. Mayo Clin Proc 39 (1964) 92-100
22. Sharkey P.C., Perry J.H., and Ehni G. Diabetes insipidus following section of the hypophyseal stalk. J Neurosurg 18 (1961) 445-460
23. Lipsett M.B., Maclean J.P., West C.D., et al. An analysis of the polyuria induced by hypophysectomy in man. J Clin Endocrinol Metab 16 2 (1956) 183-195
24. Adams J.R., Blevins Jr. L.S., Allen G.S., et al. Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution's experience. Pituitary 9 2 (2006) 93-99
25. Richardson D.W., and Robinson A.G. Desmopressin. Ann Intern Med 103 2 (1985) 228-239
26. Robertson G.L. Thirst and vasopressin function in normal and disordered states of water balance. J Lab Clin Med 101 (1983) 351-371
27. Robinson A.G., and Verbalis J.G. Diabetes insipidus. Curr Ther Endocrinol Metab 6 (1997) 1-7
28. Flear C.T., Gill G.V., and Burn J. Hyponatraemia: mechanisms and management. Lancet 2 8236 (1981) 26-31
29. Anderson R.J., Chung H.M., Kluge R., et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102 2 (1985) 164-168
30. Robinson A.G., and Verbalis J.G. The posterior pituitary. In: Larsen P.R., Kronenberg H.M., Melmed S., et al. (Eds). Williams textbook of endocrinology. 10th edition (2003), Saunders, Philadelphia 281-329
31. Spital A. Diuretic-induced hyponatremia. Am J Nephrol 19 4 (1999) 447-452
32. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 319 16 (1988) 1065-1072
33. Sane T., Rantakari K., Poranen A., et al. Hyponatremia after transsphenoidal surgery for pituitary tumors. J Clin Endocrinol Metab 79 5 (1994) 1395-1398
34. Olson B.R., Rubino D., Gumowski J., et al. Isolated hyponatremia after transsphenoidal pituitary surgery. J Clin Endocrinol Metab 80 1 (1995) 85-91
35. Ultmann M.C., Hoffman G.E., Nelson P.B., et al. Transient hyponatremia after damage to the neurohypophyseal tracts. Neuroendocrinology 56 6 (1992) 803-811
36. Palmer B.F. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab 14 4 (2003) 182-187
37. Bartter F.C. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Dis Mon (1973) 1-47
38. Peters J.P., Welt L.G., Sims E.A., et al. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 63 (1950) 57-64
39. Betjes M.G. Hyponatremia in acute brain disease: the cerebral salt wasting syndrome. Eur J Intern Med 13 1 (2002) 9-14
40. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 5 (1998) 321-328
41. Berendes E., Walter M., Cullen P., et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349 9047 (1997) 245-249
42. Maesaka J.K., Gupta S., and Fishbane S. Cerebral salt-wasting syndrome: does it exist?. Nephron 82 2 (1999) 100-109
43. Diringer M.N., Wu K.C., Verbalis J.G., et al. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol 31 5 (1992) 543-550
44. Wijdicks E.F., Vermeulen M., Hijdra A., et al. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?. Ann Neurol 17 2 (1985) 137-140
45. Halperin M.L., and Bohn D. Clinical approach to disorders of salt and water balance. Emphasis on integrative physiology. Crit Care Clin 18 2 (2002) 249-272
46. Steele A., Gowrishankar M., Abrahamson S., et al. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination. Ann Intern Med 126 1 (1997) 20-25
47. Reeder R.F., and Harbaugh R.E. Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J Neurosurg 70 2 (1989) 201-206
48. Verbalis J.G. Hyponatremia treatment guidance consensus statement. Am J Med 120 Supple 1 (2007) S1-S21
49. Verbalis J.G. Control of brain volume during hypoosmolality and hyperosmolality. Adv Exp Med Biol 576 (2006) 113-129
50. Daggett P., Deanfield J., and Moss F. Neurological aspects of hyponatraemia. Postgrad Med J 58 686 (1982) 737-740
51. Arieff A.I., Llach F., and Massry S.G. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 55 2 (1976) 121-129
52. Soupart A., and Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol 46 3 (1996) 149-169
53. Sterns R.H., and Silver S.M. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med 119 7 Suppl 1 (2006) S12-S16
54. Oh M.S., Kim H.J., and Carroll H.J. Recommendations for treatment of symptomatic hyponatremia. Nephron 70 2 (1995) 143-150
55. Tomlinson B.E., Pierides A.M., and Bradley W.G. Central pontine myelinolysis. Two cases with associated electrolyte disturbance. Q J Med 45 179 (1976) 373-386
56. Norenberg M.D., Leslie K.O., and Robertson A.S. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol 11 2 (1982) 128-135
57. Verbalis J.G. Vasopressin V2 receptor antagonists. J Mol Endocrinol 29 1 (2002) 1-9
58. Greenberg A., and Verbalis J.G. Vasopressin receptor antagonists. Kidney Int 69 12 (2006) 2124-2130
59. Lee C.R., Watkins M.L., Patterson J.H., et al. Vasopressin: a new target for the treatment of heart failure. Am Heart J 146 1 (2003) 9-18
60. Arai Y., Fujimori A., Sudoh K., et al. Vasopressin receptor antagonists: potential indications and clinical results. Curr Opin Pharmacol 7 2 (2007) 124-129
61. Vaprisol prescribing information-Astellas Pharma Inc., February 2006. Available at: http://www.astellas.us/docs/vaprisol.pdf.
62. Verbalis J.G. Vaptans for the treatment of hyponatremia: how, who, when, and why. Nephrology Self-Assessment Program (2007) 199-209